This trial examines the effects of a weekly cagrisema injection on cardiovascular outcomes in obese (>27 BMI) patients who have had cardiovascular disease.

If you have increased cardiovascular risk or established cardiovascular disease and are obese or overweight but do not have diabetes please contact us for more information: research@nightingalecardiology.com or call us on (08) 7444 4219